Supplementary Tables – A real-world US study of recurrence risks using combined clinicopathological features in HR-positive, HER2-negative early breast cancer

<strong>Table S1. Hazard Ratios from Multivariable Cox Proportional Hazards Regression Models Comparing High-risk Group with Node Negative Group (n=3424)</strong> <strong>Table S2. Hazard Ratios from Multivariable Cox Proportional Hazards Regression Models for US FDA-approved Indicated Patient Subgroup Compared with Non-high-risk Group (n=3607) </strong> <strong>Table S3. Hazard Ratios for IDFS from Two Independent Cox Proportional Hazards Regression Models for Two Different Time Periods (High-risk vs. Non-high-risk is Comparison of Interest)</strong> <strong>Table S4. Hazard Ratios for IDFS from Two Independent Cox Proportional Hazards Regression Models for Two Different Time Periods (High-risk vs. Non-high-risk is Comparison of Interest)</strong> <br>